首站-论文投稿智能助手
典型文献
Low rate of pre-exposure prophylaxis and post-exposure prophylaxis uptake and high prevalence of transmitted drug resistance among newly diagnosed primary HIV infections in Shenzhen, China: a real-world retrospective study
文献摘要:
Background::Understanding the characteristics of newly diagnosed primary human deficiency virus-1 (HIV-1) infection in the context of the post-antiretroviral therapy era and HIV drug prophylaxis is essential for achieving the new target of 95-95-95-95 by 2025. This study reported the characteristics of newly diagnosed primary HIV-1 infection in Shenzhen.Methods::This is a real-world retrospective study. Eighty-seven newly diagnosed primary HIV-1-infected patients were recruited from January 2021 to March 2022 at the Third People’s Hospital of Shenzhen. Demographic, epidemiological, diagnostic, drug resistance, and medical data were described and analyzed.Results::Overall, 96.6% (84/87) of the newly identified primary HIV-1-infected patients were male, including 88.5% (77/87) men have sex with men (MSM), with a median age of 29.0 years (Q 1-Q 3: 24.0-34.0 years); of these, 85.1% (74/87) reported high-risk sexual behaviors with casual partners. The rate of condom usage was only 28.7% (25/87). The overall rate of pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) was 8.0% (7/87, including 4 PrEP and 3 PEP cases) around the potential exposure, although 41.4% of the patients had prior awareness of such interventions. Moreover, only 19.5% (17/87) had previously used PrEP or PEP. Of those, 58.8% (10/17) of the patients obtained drugs from the internet, and only 35.3% (6/17) reported good compliance. A total of 54.0% (47/87) of subjects were diagnosed by the HIV nucleic acid test. Acute retroviral syndrome appeared in 54.0% (47/87) of patients. The prevalence of transmitted drug resistance (TDR) mutation was 33.9% (19/56), including 6 (10.7%) against nucleoside reverse transcriptase inhibitor (NRTI) plus non-nucleoside reverse transcriptase inhibitor (NNRTI), 8 (14.3%) against NNRTI, and 5 (8.9%) against protease inhibitor (PI) only. Conclusions::Owing to the low utilization rate and incorrect usage of PrEP and PEP, massive efforts are needed to promote HIV-preventive strategies in the MSM population. The extremely high prevalence of TDR mutation in this population implies the need for future pretreatment drug resistance surveillance.
文献关键词:
Antiretroviral therapy;Drug resistance;Human immunodeficiency virus-1;Post-exposure prophylaxis;Pre-exposure prophylaxis
作者姓名:
Peng Qiaoli;Liu Xiaoning;Tang Xian;Zhang Qiuyue;Zhao Jin;Zheng Chenli;Zhao Fang;Zhou Yang;Zhang Lukun;Sun Liqin;Zhang Haitao;Jia Xinyun;Song Ying;Cao Tingzhi;Wang Siyuan;Rao Man;Chen Zhiwei;Wang Hui;He Yun
作者机构:
National Clinical Research Center for Infectious Diseases, HKU AIDS Institute Shenzhen Research Laboratory, The Third People’s Hospital of Shenzhen and The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen, Guangdong 518112, China;National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London, United Kingdom;Shenzhen Center for Disease Control and Prevention, Shenzhen, Guangdong 518073, China;Department of Microbiology, AIDS Institute, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong 999077, China
引用格式:
[1]Peng Qiaoli;Liu Xiaoning;Tang Xian;Zhang Qiuyue;Zhao Jin;Zheng Chenli;Zhao Fang;Zhou Yang;Zhang Lukun;Sun Liqin;Zhang Haitao;Jia Xinyun;Song Ying;Cao Tingzhi;Wang Siyuan;Rao Man;Chen Zhiwei;Wang Hui;He Yun-.Low rate of pre-exposure prophylaxis and post-exposure prophylaxis uptake and high prevalence of transmitted drug resistance among newly diagnosed primary HIV infections in Shenzhen, China: a real-world retrospective study)[J].中华医学杂志(英文版),2022(22):2730-2737
A类:
casual
B类:
Low,exposure,prophylaxis,post,uptake,high,prevalence,transmitted,resistance,among,newly,diagnosed,primary,HIV,infections,Shenzhen,China,real,world,retrospective,study,Background,Understanding,characteristics,human,virus,context,antiretroviral,therapy,essential,achieving,target,by,This,reported,Methods,Eighty,seven,infected,patients,were,recruited,from,January,March,Third,People,Hospital,Demographic,epidemiological,diagnostic,medical,data,described,analyzed,Results,Overall,identified,male,including,have,MSM,median,years,Q ,these,risk,sexual,behaviors,partners,condom,usage,was,only,overall,PrEP,PEP,cases,around,potential,although,had,prior,awareness,such,interventions,Moreover,previously,used,Of,those,obtained,drugs,internet,good,compliance,total,subjects,nucleic,acid,test,Acute,syndrome,appeared,TDR,mutation,against,nucleoside,reverse,transcriptase,inhibitor,plus,NNRTI,protease,Conclusions,Owing,low,utilization,incorrect,massive,efforts,needed,promote,preventive,strategies,population,extremely,this,implies,future,pretreatment,surveillance,Antiretroviral,Drug,Human,immunodeficiency,Post,Pre
AB值:
0.485996
相似文献
Clinical management and survival outcomes of patients with different molecular subtypes of diffuse gliomas in China (2011–2017): a multicenter retrospective study from CGGA
Kenan Zhang;Xing Liu;Guanzhang Li;Xin Chang;Shouwei Li;Jing Chen;Zheng Zhao;Jiguang Wang;Tao Jiang;Ruichao Chai-Department of Molecular Pathology,Beijing Neurosurgical Institute,Capital Medical University,Beijing 100070,China;Department of Neuropathology,Beijing Neurosurgical Institute,Capital Medical University,Beijing 100070,China;Department of Neurosurgery,Beijing Tiantan Hospital,Capital Medical University,Beijing 100070,China;Department of Neurosurgery,Beijing Sanbo Brain Hospital,Capital Medical University,Beijing 100093,China;Division of Life Science and State Key Laboratory of Molecular Neuroscience,Department of Chemical and Biological Engineering,The Hong Kong University of Science and Technology,Clear Water Bay,Kowloon,Hong Kong SAR 999077,China;Hong Kong Center for Neurodegenerative Diseases,Hong Kong Science Park,Hong Kong SAR 999077,China;HKUST Shenzhen-Hong Kong Collaborative Innovation Research Institute,Futian,Shenzhen 518057,China
Treatment outcomes of HIV patients with hepatitis B and C virus co-infections in Southwest China: an observational cohort study
Jia Jingya;Zhu Qiuying;Deng Luojia;Lan Guanghua;Johnson Andrew;Chen Huanhuan;Shen Zhiyong;Li Jianjun;Xing Hui;Ruan Yuhua;Li Jing;Lu Hui;Vermund Sten H.;Zhu Jinhui;Qian Han-Zhu-SJTU-Yale Joint Center for Biostatistics and Data Science, Shanghai Jiao Tong University, Shanghai, China;Department of Bioinformatics and Biostatistics, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China;Guangxi Key Laboratory of Major Infectious Disease Prevention Control and Biosafety Emergency Response, Guangxi Center for Disease Control and Prevention, Nanning, China;Groton School, Groton, MA, USA;State Key Laboratory of Infectious Disease Prevention and Control (SKLID), Chinese Center for Disease Control and Prevention (China CDC), Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Beijing, China;School of Public Health, Yale University, New Haven, CT, USA
Non-traumatic coma in young children in Benin: are viral and bacterial infections gaining ground on cerebral malaria?
Brisset Josselin;Baki Karl Angendu;Watier Laurence;Kinkpé Elisée;Bailly Justine;Ayédadjou Linda;Alao Maroufou Jules;Dossou-Dagba Ida;Bertin Gwladys I.;Cot Michel;Boumédiène Farid;Ajzenberg Daniel;Aubouy Agnès;Houzé Sandrine;Faucher Jean-Fran?ois;NeuroCM Group-Infectious Diseases and Tropical Medicine Department, Limoges University Hospital, 2 Avenue Martin Luther King, 87000 Limoges, France;Inserm UMR 1094, IRD U270, EpiMaCT-Epidemiology of chronic diseases in tropical zone, Institute of Epidemiology and Tropical Neurology, OmegaHealth, Univ. Limoges, CHU Limoges, Limoges, France;Center for Research in Epidemiology and Population Health (CESP), INSERM U1018, Paris-Saclay University, UVSQ, Montigny-Le-Bretonneux, France;Epidemiology and Modeling of Bacterial Evasion to Antibacterials Unit (EMEA), Institut Pasteur, 25-28, Rue du Dr. Roux, 75724 Paris Cedex 15, France;Paediatric Department, Calavi Hospital, Calavi, Benin;UMR261 MERIT, IRD, Université de Paris, 75006 Paris, France;French Malaria Reference Center, H?pital Bichat, APHP, Paris, France;Paediatric Department, Mother and Child University and Hospital Center (CHU-MEL), Cotonou, Benin;Clinical Research Institute of Benin (IRCB), Abomey Calavi, Benin;UMR152 PHARMADEV, Université de Toulouse, IRD, UPS, Toulouse, France;Parasitology Laboratory, Hopital Bichat-Claude-Bernard, APHP, Paris, France
Profile and determinants of delayed care-seeking and diagnosis among patients with imported malaria: a retrospective study in China, 2014–2021
Zhang Tao;Wang Duoquan;Qian Yingjun;Ruan Wei;Liu Ying;Xia Jing;Yan Hui;Sui Yuan;Lu Shenning;Xu Xian;Jiang Jingjing;Lyu Xiaofeng;Wang Shuqi;Li Shizhu;Li Weidong-Anhui Provincial Center for Disease Control and Prevention, Hefei 230601, China;National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention (Chinese Center for Tropical Diseases Research), NHC Key Laboratory of Parasite and Vector Biology, WHO Collaborating Center for Tropical Diseases, National Center for International Research on Tropical Diseases, Shanghai 200025, China;School of Global Health, Chinese Center for Tropical Diseases Research, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China;Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou 310051, China;Henan Provincial Center for Disease Control and Prevention, Zhengzhou 450016, China;Hubei Provincial Center for Disease Control and Prevention, Wuhan 430079, China;Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention, Nanning 530028, China;Brown School, Washington University, St. Louis, MO, USA
Global prevalence, mortality, and main risk factors for COVID-19 associated pneumocystosis: A systematic review and meta-analysis
Hossein Khodadadi;Ehsan Ahmadpour;Sanam Nami;Rasoul Mohammadi;Hanieh Hosseini;Mahsa Behravan;Hamid Morovati-Department of Parasitology and Mycology,School of Medicine,Shiraz University of Medical Sciences,Shiraz,Iran;Drug Applied Research Center,Tabriz University of Medical Sciences,Tabriz,Iran;Department of Medical Mycology and Parasitology,School of Medicine,Tabriz University of Medical Sciences,Tabriz,Iran;Department of Medical Parasitology and Mycology,School of Medicine,Isfahan University of Medical Sciences,Isfahan,Iran;Immunology Research Center,Tabriz University of Medical Sciences,Tabriz,Iran;Student Research Committee,Shiraz University of Medical Sciences,Shiraz,Iran
Bacteremia tuberculosis among HIV-negative children in China
Chu Ping;Shi Jin;Dong Fang;Yang Hui;Zhao Shunying;Liu Gang;Zheng Huyong;Liu Jinrong;Li Huimin;Lu Jie-Beijing Key Laboratory for Pediatric Diseases of Otolaryngology, Head and Neck Surgery, Beijing Pediatric Research Institute, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China;Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, Beihang University & Capital Medical University, Beijing, China;Department of Tuberculosis, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, Capital Medical University, Beijing, China;Department of Laboratory Medicine, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China;Department 2 of Respiratory Medicine, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China;Department of Infectious Disease, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China;Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics, Ministry of Education, Key Laboratory of Major Diseases in Children, Ministry of Education, Hematology Oncology Center, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, China
Clinical outcomes of atezolizumab in combination with etoposide/platinum for treatment of extensive-stage small-cell lung cancer:A real-world,multicenter,retrospective,controlled study in China
Hanxiao Chen;Xiangjuan Ma;Jie Liu;Yu Yang;Yong Fang;Liping Wang;Jian Fang;Jun Zhao;Minglei Zhuo-Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department Ⅰ of Thoracic Oncology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department Ⅱ of Thoracic Oncology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Department of Pneumology,Shandong Cancer Hospital and Institute,Shandong First Medical University and Shandong Academy of Medical Sciences,Jinan 250117,China;Department of Oncology,the 2nd Affiliated Hospital of Harbin Medical University,Harbin 150001,China;Department of Oncology,Sir Run Run Shaw Hospital Zhejiang University School of Medicine,Hangzhou 310020,China;Department of Oncology,Baotou Cancer Hospital,Baotou 014030,China
Adjuvant tamoxifen switched to exemestane treatment in postmenopausal women with estrogen receptor-positive early breast cancer: A pragmatic, multicenter, and prospective clinical trial in China
Binghe Xu;Huiping Li;Zefei Jiang;Lin Gu;Jinhai Tang;Hui Xie;Yueyin Pan;Yunjiang Liu;Shude Cui;Xiaojia Wang;Li Cai;Yiqiong Zhang;Huadong Zhao;Zhimin Shao-Department of Medical Oncology,National Cancer Center/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Breast Oncology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Department of Breast Cancer,the Fifth Medical Center of Chinese PLA General Hospital,Beijing 100071,China;Department of Breast Cancer,Tianjin Cancer Institute and Hospital,Tianjin 300060,China;Department of Breast Cancer,Jiangsu Provincial Hospital,Nanjing 210029,China;Department of Breast Cancer,the First Affiliated Hospital of China University of Science and Technology,Hefei 230001,China;Department of Breast Cancer,the Fourth Hospital of Hebei Medical University,Shijiazhuang 050011,China;Department of Breast Cancer,Henan Cancer Hospital,Zhengzhou 450008,China;Department of Breast Cancer,Zhejiang Cancer Hospital,Hangzhou 310012,China;Department of Breast Cancer,Harbin Medical University Cancer Hospital,Harbin 150081,China;Department of Clinical Development,Pfizer(China)R&D Co.Ltd,Shanghai 201203,China;Department of Statistics,Pfizer(China)R&D Co.Ltd,Shanghai 201203,China;Department of Breast Surgery,Shanghai Cancer Center/Cancer Institute,Shanghai Medical College,Fudan University,Shanghai 200032,China
Epidemiological characteristics and disease burden of infectious mononucleosis in hospitalized children in China:A nationwide retrospective study
Mengjia Liu;Xinyu Wang;Linlin Zhang;Guoshuang Feng;Yueping Zeng;Ran Wang;Zhengde Xie-Beijing Key Laboratory of Pediatric Respiratory Infectious Diseases,Key Laboratory of Major Diseases in Children,Ministry of Education,National Clinical Research Center for Respiratory Diseases,Laboratory of Infection and Virology,Beijing Pediatric Research Institute,Beijing Children's Hospital,Capital Medical University,National Center for Children's Health,Beijing,100045,China;Research Unit of Critical Infection in Children,2019RU016,Chinese Academy of Medical Sciences,Beijing China;Big Data Center,Beijing Children's Hospital,Capital Medical University,National Center for Children's Health,Beijing,100045,China;Medical Record Management Office Beijing Children's Hospital,Capital Medical University,National Center for Children's Health,Beijing,100045,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。